Skip to content
Clinical Trials – home

Dry age-related macular degeneration

  • 15 clinical trials
Quick filters

15 Clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:XELAFASLATIDE
  • Sponsor:ONL Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
  • Sponsor:Galimedix Therapeutics Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Janssen Cilag International
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tinlarebant
  • Sponsor:Belite Bio Inc.
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.